Art Fratamico Email

President and CEO . Radiant Biotherapeutics

Current Roles

Employees:
26
Revenue:
$5M
About
Radiant’s Multabody™ platform enables multi-valent, multi-specific antibodies that have the potential to transform the treatment of cancer, inflammation, infections and other heterogeneous diseases. This breakthrough in antibody engineering combines avidity – superior binding power – with multi-specificity to create multifunctional biologics with the potential to unlock biology not achievable with current antibodies. Multabodies are a new class of biologics built on a modular, fully human scaffold, simplifying development while leveraging existing antibody manufacturing processes. We are rapidly advancing this superior next-generation therapeutic platform for a variety of indications. Learn more at radiantbio.com.\n \n\n \n \n Show more\n \n\n \n\n\n \n \n Show less
Radiant Biotherapeutics Address

Toronto, ON
CAN
Radiant Biotherapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.